PMID- 11438648 OWN - NLM STAT- MEDLINE DCOM- 20010816 LR - 20181113 IS - 0270-7306 (Print) IS - 1098-5549 (Electronic) IS - 0270-7306 (Linking) VI - 21 IP - 15 DP - 2001 Aug TI - Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions. PG - 4909-18 AB - Cells utilize ubiquitin-mediated proteolysis to regulate the activity of numerous proteins involved in signal transduction, cell cycle control, and transcriptional regulation. For a number of transcription factors, there appears to be a direct correlation between transcriptional activity and protein instability, suggesting that cells use targeted destruction as one method to down-regulate or attenuate gene expression. In this report we demonstrate that retinoid X receptors (RXRs) which function as versatile mediators of nuclear hormone-dependent gene expression are marked for destruction upon binding agonist ligands. Interestingly, when RXR serves as a heterodimeric partner for retinoic acid (RAR) or thyroid hormone (TR) receptors, binding of agonists by RAR or TR leads to degradation of both the transcriptionally active RAR or TR subunits as well as the transcriptionally inactive RXR subunit. Furthermore, using a series of mutants in the ligand-dependent activation domain (activation function 2), we demonstrate that agonist-stimulated degradation of RXR does not require corepressor release, coactivator binding, or transcriptional activity. Taken together, the data suggest a model for targeted destruction of transcription factors based on structural or conformational signals as opposed to functional coupling with gene transcription. FAU - Osburn, D L AU - Osburn DL AD - Nuclear Receptor Discovery, Ligand Pharmaceuticals, San Diego, California 92121, USA. FAU - Shao, G AU - Shao G FAU - Seidel, H M AU - Seidel HM FAU - Schulman, I G AU - Schulman IG LA - eng PT - Journal Article PL - United States TA - Mol Cell Biol JT - Molecular and cellular biology JID - 8109087 RN - 0 (Ligands) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Receptors, Thyroid Hormone) RN - 0 (Retinoid X Receptors) RN - 0 (Transcription Factors) RN - 0 (Ubiquitins) SB - IM MH - Animals MH - Blotting, Western MH - Cell Line MH - Cell Nucleus/metabolism MH - Cells, Cultured MH - Dimerization MH - Enzyme Activation MH - Ligands MH - Mutation MH - Plasmids/metabolism MH - Precipitin Tests MH - Protein Binding MH - Protein Conformation MH - Protein Structure, Tertiary MH - Receptors, Retinoic Acid/*metabolism MH - Receptors, Thyroid Hormone/metabolism MH - Retinoid X Receptors MH - Signal Transduction MH - Time Factors MH - Transcription Factors/*metabolism MH - *Transcription, Genetic MH - Transcriptional Activation MH - Transfection MH - Ubiquitins/metabolism PMC - PMC87210 EDAT- 2001/07/05 10:00 MHDA- 2001/08/17 10:01 PMCR- 2001/08/01 CRDT- 2001/07/05 10:00 PHST- 2001/07/05 10:00 [pubmed] PHST- 2001/08/17 10:01 [medline] PHST- 2001/07/05 10:00 [entrez] PHST- 2001/08/01 00:00 [pmc-release] AID - 2074 [pii] AID - 10.1128/MCB.21.15.4909-4918.2001 [doi] PST - ppublish SO - Mol Cell Biol. 2001 Aug;21(15):4909-18. doi: 10.1128/MCB.21.15.4909-4918.2001.